Ελευθερία Χατζημιχαήλ: «Οι κλινικές μελέτες δεν είναι η έσχατη λύση όταν όλα τα άλλα έχουν αποτύχει. Είναι η πρώτη γραμμή της σύγχρονης, ποιοτικής ιατρικής φροντίδας» https://t.co/6AHHiWchQT
DLBCL isn't just about the B cells! 🧬 The Tumor Microenvironment (TME) acts as a battleground where TAMs and T-cells decide the fate of treatment. New "microenvironment subtyping" is now helping predict which patients will beat the odds. #Lymphoma
More : https://t.co/mFIDVB8wdL
Unraveling the Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic and Potential Therapeutic Implications https://t.co/MjvWx6IPCA #mdpicimb via @CIMB_MDPI
A real pleasure to give the Keynote lecture “MDS: Progress & challenges” at a meeting of University of Alexandroupolis, Greece 🇬🇷 & to meet with the Hellenic #MDSsm group. Nothing excites me more than collaborating to advance care for #MDSsm patients worldwide 🌎 @YaleCancer
@Dr_AmerZeidan@LeonidasPlatan1 Thank you so much for visiting Greece and for such a great talk! We really enjoyed it. Looking forward to your next visit ☺️
#anemia#Luspatercept
👏Welcome to read the High-citation #Review: Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis. @ehatzim
More information👉 https://t.co/MuYrm2ydlG
🥳Diseases, Volume 12, Issue 3 has been released! Visit https://t.co/tkYp6q6Eky to browse the papers.
📚Check the cover paper authored by Eleftheria Hatzimichael et al. @ehatzim
🔗https://t.co/8THoeAmTub